{'fraction_non_alphanumeric': 0.024305555555555556, 'fraction_numerical': 0.011574074074074073, 'mean_word_length': 5.091549295774648, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Presence of estrogen receptors in the hen hypothalamus and pituitary.

In the hen, the preoptic area, medial basal hypothalamus, and anterior lobe of the pituitary showed a greater uptake of [3H]estradiol-17 beta (E2) in vivo than other tissues. This uptake was decreased when unlabeled diethylstilbestrol was injected together with the [3H]E2 or when unlabeled E2 was injected before the [3H]E2 injection. A specific estrogen binding component having properties of a receptor was found in vitro in both soluble and insoluble fractions of these tissues in a hypotonic buffer solution. The administration of E2 in vivo caused a marked decrease in the estrogen receptor binding in the soluble fraction with a concomitant increase in binding in the insoluble fraction; as a result, total binding (sum of the bindings in soluble and insoluble fraction) did not change.